Bioasis Technologies Inc.
BIOAF
$0.00
$0.00-66.67%
OTC PK
| 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | |
|---|---|---|---|---|---|
| Net Income | 27.83% | -81.50% | 57.93% | 47.90% | -248.64% |
| Total Depreciation and Amortization | 136.70% | 120.91% | -6.19% | 17.58% | 0.93% |
| Total Amortization of Deferred Charges | -19.66% | 43.57% | -- | 10,505.26% | -- |
| Total Other Non-Cash Items | -78.62% | 136.40% | -229.59% | -130.85% | 115.97% |
| Change in Net Operating Assets | 211.72% | 249.19% | 143.48% | -14.26% | -834.52% |
| Cash from Operations | 56.34% | 82.09% | 28.45% | -186.56% | -15.26% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | 100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -77.94% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -- | -120.11% | 100.00% |
| Foreign Exchange rate Adjustments | 157.14% | -43.67% | 96.94% | 94.18% | -50.54% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 58.95% | -111.49% | -9.09% | -1,723.21% | -232.29% |